Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-17-020930
Filing Date
2017-04-18
Accepted
2017-04-18 17:17:55
Documents
1
Period of Report
2017-04-18

Document Format Files

Seq Description Document Type Size
1 PRE 14A v464490_pre14a.htm PRE 14A 285419
  Complete submission text file 0001144204-17-020930.txt   286439
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37758 | Film No.: 17767610
SIC: 2834 Pharmaceutical Preparations